Deep Track Capital, LP Iveric Bio, Inc. Transaction History

Deep Track Capital, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$18.67 - $24.56 $25.7 Million - $33.8 Million	-1,378,119 Reduced 17.49%	6,500,000 $158 Million
Q4 2022 Feb 14, 2023	BUY	$17.24 - $23.95 $15.1 Million - $21 Million	878,119 Added 12.54%	7,878,119 $169 Million
Q3 2022 Nov 14, 2022	BUY	$9.4 - $18.59 $23.5 Million - $46.5 Million	2,500,000 Added 55.56%	7,000,000 $126 Million
Q1 2022 May 16, 2022	BUY	$12.15 - $16.83 $6.08 Million - $8.42 Million	500,000 Added 12.5%	4,500,000 $75.7 Million
Q4 2021 Feb 14, 2022	BUY	$13.83 - $18.78 $55.3 Million - $75.1 Million	4,000,000 New	4,000,000 $66.9 Million

250K

40K

Ticker ISEE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,078,000
Description
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...

Get notified when there are updates to the investment portfolio of Deep Track Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Deep Track Capital, LP with notifications on news.